GB202110329D0 - Therapeutic - Google Patents

Therapeutic

Info

Publication number
GB202110329D0
GB202110329D0 GB202110329A GB202110329A GB202110329D0 GB 202110329 D0 GB202110329 D0 GB 202110329D0 GB 202110329 A GB202110329 A GB 202110329A GB 202110329 A GB202110329 A GB 202110329A GB 202110329 D0 GB202110329 D0 GB 202110329D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB202110329A
Other versions
GB2608865A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Al Ahliyya Amman Univ
Original Assignee
Al Ahliyya Amman Univ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Al Ahliyya Amman Univ filed Critical Al Ahliyya Amman Univ
Priority to GB2110329.6A priority Critical patent/GB2608865A/en
Publication of GB202110329D0 publication Critical patent/GB202110329D0/en
Publication of GB2608865A publication Critical patent/GB2608865A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
GB2110329.6A 2021-07-19 2021-07-19 Therapeutic Pending GB2608865A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2110329.6A GB2608865A (en) 2021-07-19 2021-07-19 Therapeutic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2110329.6A GB2608865A (en) 2021-07-19 2021-07-19 Therapeutic

Publications (2)

Publication Number Publication Date
GB202110329D0 true GB202110329D0 (en) 2021-09-01
GB2608865A GB2608865A (en) 2023-01-18

Family

ID=77445631

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2110329.6A Pending GB2608865A (en) 2021-07-19 2021-07-19 Therapeutic

Country Status (1)

Country Link
GB (1) GB2608865A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1748679A (en) * 2004-09-14 2006-03-22 郑文婕 Mebendazole new form for treating allergic rhinitis
WO2017141137A1 (en) * 2016-02-16 2017-08-24 Shoket Latief A composition and dosage form for reducing an hiv viral load
GB201721287D0 (en) * 2017-12-19 2018-01-31 Repos Pharma Ab Treatment for inflammatory disease

Also Published As

Publication number Publication date
GB2608865A (en) 2023-01-18

Similar Documents

Publication Publication Date Title
GB202001980D0 (en) Therapeutic mentods
GB202006960D0 (en) Therapeutic
GB202108303D0 (en) Therapy
GB202111288D0 (en) Combination therapy
GB202004189D0 (en) Combination therapy
GB202110329D0 (en) Therapeutic
GB202203017D0 (en) Novel therapeutic
GB202117706D0 (en) Therapy
GB202111035D0 (en) Therapy
GB202109893D0 (en) PeptiBAC therapy
GB202104427D0 (en) Therapy
GB202103164D0 (en) Therapy
GB202102211D0 (en) PeptiBAC therapy
GB202019218D0 (en) Therapy
GB202017598D0 (en) Therapy
GB202017554D0 (en) Therapy
GB202015778D0 (en) Therapy
GB202015780D0 (en) Therapy
GB202013824D0 (en) PeptiBAC therapy
GB202013834D0 (en) PeptiVAX therapy
GB202009039D0 (en) Therapy
GB202008031D0 (en) Therapy
GB202004629D0 (en) Therapy
GB202004013D0 (en) Therapy
GB202002639D0 (en) Therapy